Quantum Biology · Anno MMXXVI

Meg-Apsu

A classifier that reads an enzyme's structure and asks whether it works by the quantum tunnel
Sabrina Hackfort · Independent Researcher · ORCID 0009-0007-7458-2487
❦ ❦ ❦

Some enzymes move a hydrogen by letting it tunnel through the energy barrier rather than over it. Whether an enzyme does this cannot be read off its name; it depends on the geometry of its active site. MEG-APSU takes an enzyme's structure, runs it through an open-quantum-system model, and places it on one side of a line: quantum-critical, or classical. It is the engine that TERRA uses to scan species, and its honest worth is exactly as good as that line is drawn.

The method

From the active-site geometry, MEG-APSU builds a small open-quantum-system (Lindblad) model of the hydrogen-transfer step and reads out how much of the rate the tunnel carries. A threshold on that quantity decides the label. It is written in Rust, from structure to classification.

Honest Accuracy

A classifier is only as trustworthy as the test it has not seen. MEG-APSU is measured on a frozen set of 40 proteins, split so that no protein family appears in both training and test. On that set, version 1.3 is right 92.5 % of the time. The simplest sensible rule — guess from the cofactor alone — gets 75 %. So the quantum model earns its keep, but it is not magic.

cofactor baseline
guess from cofactor only
75.0 %
MEG-APSU v1.2
earlier version
80.0 %
MEG-APSU v1.3
current
92.5 %
Accuracy on the frozen 40-protein test set, family-split, classification threshold 10. The shaded band on v1.3 is the 95 % confidence interval (80–97 %) — with only 40 proteins the number carries real uncertainty, and that band is part of the honest result. v1.3 clears both the earlier version and the cofactor baseline.

What Changed, and Why the Old 100 % Was Wrong

An earlier version reported 100 % accuracy. It was not real. The decision threshold had been tuned on the very proteins used to test it, and several heme proteins — myoglobin, haemoglobin, cytochrome c — were being called quantum-critical when they are not. Version 1.3 adds a filter for metal-catalytic sites and separates the development set from the test set properly. The honest number fell from 100 % to 92.5 %, and that fall is the point: a model that cannot be wrong on paper cannot be trusted in the world.

Applied to Drug Targets

Run across 115 FDA-target enzymes, MEG-APSU labels about 35.7 % of them quantum-critical. That figure should be read through the accuracy above: it is a classifier's estimate at 92.5 % per-enzyme reliability, not a verified count. It is a map of where to look, not a verdict on each target.

What It Does Not Claim

Three proteins are still misread on the test set — flavodoxin, haemerythrin, bacterioferritin — and the aconitase label is uncertain. The model's prediction of the kinetic isotope effect is weak (ρ = 0.19): it sorts enzymes into the right bin better than it predicts their exact numbers. And 40 proteins is a small test; the confidence interval says so plainly. The next version is meant to re-check the labels against direct tunnelling evidence and to grow the test set.

Preprint: bioRxiv 2026/713696 · Zenodo 10.5281/zenodo.19208904 · Code: github.com/sectio-aurea-q/meg-apsu